Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
JACC · 2024-10 · 84 (15) · 1391-1403
DOI: 10.1016/j.jacc.2024.06.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2024-10. Verfasst von Valentin Fuster und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Mount Sinai Fuster Heart Hospital, New York, New York, USA. Electronic…. Hauptthemen laut MEDLINE: Disease Progression, Atherosclerosis. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Atherosclerosis is a dynamic process. There is little evidence regarding whether quantification of atherosclerosis extent and progression, particularly in the carotid artery, in asymptomatic individuals predicts all-cause mortality. OBJECTIVES: This study sought to evaluate the independent predictive value (beyond cardiovascular risk factors) of subclinical atherosclerosis burden and progression and all-cause mortality. METHODS: A population of 5,716 asymptomatic U.S. adults (mean age 68.9 years, 56.7% female) enrolled between 2008 and 2009 in the BioImage (A Clinical Study of Burden of Atherosclerotic Disease in an At Risk Population) study underwent examination by vascular ultrasound to quantify carotid plaque burden (cPB) (the sum of right and left carotid plaque areas) and by computed tomography for coronary artery calcium (CAC). Follow-up carotid vascular ultrasound was performed on 732 participants a median of 8.9 years after the baseline exam. All participants were followed up for all-cause mortality, the primary outcome. Trend HRs are the per-tertile increase in each variable. RESULTS: Over a median 12.4 years' follow-up, 901 (16%) participants died. After adjustment for cardiovascular risk factors and background medication, baseline cPB and CAC score were both significantly associated with all-cause mortality (fully adjusted trend HR: 1.23; 95% CI: 1.16-1.32; and HR: 1.15; 95% CI: 1.08-1.23), respectively (both P < 0.001), thus providing additional prognostic value. cPB performed better than CAC score. In participants with a second vascular ultrasound evaluation, median cPB progressed from 29.2 to 91.3 mm3. cPB progression was significantly associated with all-cause mortality after adjusting for cardiovascular risk factors and baseline cPB (HR: 1.03; 95% CI: 1.01-1.04 per absolute 10-mm3 change; P = 0.01). CONCLUSIONS: Subclinical atherosclerosis burden (cPB and CAC) in asymptomatic individuals was independently associated with all-cause mortality. Moreover, atherosclerosis progression was independently associated with all-cause mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Mount Sinai Fuster Heart Hospital, New York, New York, USA. Electronic address: vfuster@cnic.es.
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Cardiology Department, Hospital Clínic Barcelona and August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain; Universitat de Barc…
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Mount Sinai Fuster Heart Hospital, New York, New York, USA.
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Madrid, Spain.
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Madrid, Spain; Cardiology Department, University Hospital La Mora…
Zitieren
APA
Fuster, V., García-Álvarez, A., Devesa, A., Mass, V., Owen, R., Quesada, A., Fuster, J. J., García-Lunar, I., Pocock, S., Sánchez-González, J., Sartori, S., Peyra, C., Andres, V., Muntendam, P., & Ibanez, B. (2024). Influence of Subclinical Atherosclerosis Burden and Progression on Mortality. JACC, 84(15), 1391-1403. https://doi.org/10.1016/j.jacc.2024.06.045
Vancouver
Fuster V, García-Álvarez A, Devesa A, Mass V, Owen R, Quesada A, et al. Influence of Subclinical Atherosclerosis Burden and Progression on Mortality. JACC. 2024;84(15):1391-1403. doi:10.1016/j.jacc.2024.06.045
BibTeX
@article{Fuster2024,
author = {Fuster, Valentin and García-Álvarez, Ana and Devesa, Ana and Mass, Virginia and Owen, Ruth and Quesada, Antonio and Fuster, José J and García-Lunar, Inés and Pocock, Stuart and Sánchez-González, Javier and Sartori, Samantha and Peyra, Carlos and Andres, Vicente and Muntendam, Pieter and Ibanez, Borja},
title = {Influence of Subclinical Atherosclerosis Burden and Progression on Mortality},
journal = {JACC},
year = {2024},
volume = {84},
number = {15},
pages = {1391--1403},
doi = {10.1016/j.jacc.2024.06.045}
}
EUVIMED